(OTC:IVOB) reported a narrowed annual loss, due in part to changes in the market value of the company’s derivative warrant liability.
Apollo Endosurgery secures $50m loan
Apollo Endosurgery said it secured a $50 million term loan from Athyrium Capital Management it plans to use to refinance its debt.
RayVio exits stealth mode with $9.3m Series B
RayVio emerged from stealth mode with a $9.3 million Series B round it plans to use on developing its UV LED technology.
Participants in the round included new investors Applied Ventures, Augment Ventures, New Ground Ventures and Tolero Ventures. Existing backers DCM Ventures and Capricorn Investment Group also participated.
Steris, Synergy delay merger vote over FTC request
Diabetes: Tandem closes $60m offering
Tandem Diabetes Care (NSDQ:TNDM) this week said it closed on a previously announced public offering valued at around $60 million.
Bankrupt NuOrtho Surgical looks to liquidate
After a 7-year run Fall River, Mass.-based NuOrtho Surgical filed for Chapter 7 bankruptcy, listing liabilities of $4.74 million and assets of $287,117. Nearly 40 patents were also cited in the filing, some of which had been used as collateral.
FDA to hold robotics regulation workshop
Teleflex expands Class 1 recall, posts Q4 earnings beat
Sotera acquires sensor developer Reflectance Medical
Wearables maker Sotera Wireless said yesterday that it acquired sensor developer Reflectance Medical Inc. for an undisclosed amount.
Bill to protect FDA user fees introduced in the U.S. House of Representatives
Tattoo removal: FDA clears Cynosure’s 532 nm laser system
The FDA has cleared Cynosure’s (NSDQ:CYNO) 532 nm Laser Delivery System for its PicoSure tattoo-removal technology platform.
Cynosure said the regulatory win will enable the PicoSure system to remove all colors of ink in fewer sessions.